MINT-QUETIAPINE XR
MINT PHARMACEUTICALS INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of MINT-QUETIAPINE XR in Canada?
Not currently. The most recent shortage report for MINT-QUETIAPINE XR 50MG is marked resolved (last updated September 23, 2026).
Why Psychiatric Medications Keep Going Into Shortage in Canada
Why antidepressants and antipsychotics like buspirone, quetiapine, escitalopram, venlafaxine, and paroxetine show up in Canadian shortage reports so often, and what to do if yours is affected.
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
02522187
Strength
50MG
Dosage Form
TABLET (EXTENDED-RELEASE)
Route
ORAL
Active Ingredient
QUETIAPINE
Tier
Unrated
Last Updated
2026-09-23
Reason for Shortage
Disruption of the manufacture of the drug.
Other Products from MINT PHARMACEUTICALS INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
300MG · DIN 02480956
10MG · DIN 02468840
25MG · DIN 02468859
800MG · DIN 02524724
400MG · DIN 02524716
200MG · DIN 02524708
70.0MG · DIN 02394871
10MG · DIN 02362678
5MG · DIN 02362651
1MG · DIN 02393573
5MG · DIN 02495449
2.5MG · DIN 02495430